lain was appointed to the board in August 2009 and is responsible for research strategy and its implementation. He oversees CRUK’s portfolio of research across discovery science, translational research, clinical and population research. This research portfolio includes international Grand Challenges, our clinical trial portfolio and oversight of our Institutes and Centres.
As CEO of Cancer Research Technology he is also responsible for ensuring research is developed and commercialised, often in partnership with biotech and pharmaceutical companies to ensure the outputs of research reach patients as rapidly and effectively as possible.
lain began his career as a research scientist, completing his PhD at the Cancer Research UK Beatson Institute, before becoming a science writer and medical journalist and joining CRUK.